Issue link: https://www.e-digitaleditions.com/i/1546950
This section provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No endorsement or preference is intended. 18 OctOber 2026 Inhalation ISSUE FOCUS Devices This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No product endorsement or preference is intended. Advancing connected workflows in inhaler testing Inhaler testing workflows often span multiple sys- tems, records and pieces of equipment. Bringing the workflow together within one connected environ- ment can reduce manual data handling and support greater control, consistency and traceability. Copley is advancing this approach through Inhalytix ® + v2.0, its digital hub for inhaler testing data management and compatible connected equipment, including the new Critical Flow Controller TPK 200iX. Together, they help laboratories manage more of the testing work- flow as a connected process, providing clearer over- sight of the way tests are carried out and recorded. is supports a more complete, controlled test record. Copley Scientific UK: +44 1159 616229 info@copleyscientific.com www.copleyscientific.com Design and supply of inhalers for future respiratory therapies Merxin Ltd designs and supplies dry powder and soft mist inhalers that support established and emerging inhaled therapies. We are proudly embracing the future of RNA and biologics therapies with our MRX003 capsule DPI, MRX004 SMI and MRX006 multidose DPI. We also support the industry's transition from HFA pMDIs to inhalation technologies with lower global warming potential: MRX004, which main- tains treatment efficacy while reducing environmental impact, and MRX002+, our see-through R&D pMDI vial. We were awarded the King's Award for Enterprise: Innovation 2026, recognizing our device development and IP creation. Partner with Merxin Ltd to launch your respiratory pipeline. #WeWillLaunchYou. Merxin Ltd UK: +44 1553 403070 info@merxin.com www.merxin.com Respiratory drug product development software Fusion Process Development (FPD) for respiratory drug product R&D is the perfect companion mod- ule to Fusion Inhaler Testing (FIT) for QC. FPD has automated Design of Experiments (DoE) and data modeling for formulation and process R&D. FPD enables you to create companion testing designs for your formulation and device design studies with full bi-directional Chromatography Data Software (CDS) testing automation. Automated CDS testing and data retrieval includes handling of complex data from cas- cade impaction testing and dissolution testing. And FPD operates under full regulatory compliance to maintain data integrity. S-Matrix ® US: +1 707 441-0406 sales@smatrix.com www.smatrix.com

